AbboMax, Inc logo — An innovative antibody and assay development company located...

AbboMax, Inc

An innovative antibody and assay development company located in Silicon Valley Center, California

Founded 2005 United States San Jose, United States 4 employees Venture round Total: $2.50M Biotechnology, Health Care +2

General Information

Company Name AbboMax, Inc
Founded Year 2005
Location United States San Jose, United States
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with AbboMax, Inc. To contact AbboMax, Inc, visit abbomax.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AbboMax, Inc compare?

A PDF of AbboMax, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AbboMax, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AbboMax, Inc

AbboMax, Inc. is a biotechnology company founded in 2005, specializing in immunohistochemistry (IHC) and in situ hybridization (ISH) products and assay development. Based in Silicon Valley Core Facility in San Jose, California, the company offers high-quality custom service and products, with a focus on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellet slides, tissue/cell blocks, Tissue Microarray (TMA), and CRO services. The services provided by AbboMax include recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), and scale-up processes for pharmaceutical companies and CLIA labs. AbboMax received a significant $1.50M Venture Round investment on 15 October 2015 from Yuan Zhou. The company operates primarily in the biotechnology, health care, manufacturing, and pharmaceutical industries.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.50M 1
Yuan Zhou
15 Oct 2015
Seed Round $1.00M -
22 Jan 2008

AbboMax, Inc Alternatives & Competitors

View All Alternatives
AbboMax, Inc vs

Supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents...

8 employees
Biotechnology, Health Care
AbboMax, Inc vs

Technologies for Better Life CrossLife Technologies is a life sciences company founded with t...

Grant
6 employees
Biotechnology, Health Care
AbboMax, Inc vs
Bio Synthesis
Bio Synthesis United States

Life Sciences Company

43 employees
Biotechnology, Health Care

FAQ About AbboMax, Inc

An innovative antibody and assay development company located in Silicon Valley Center, California
AbboMax, Inc was founded in 2005.
AbboMax, Inc is headquartered in San Jose, United States.
AbboMax, Inc operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical.
AbboMax, Inc has approximately 4 employees.
AbboMax, Inc has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Venture round.
Top alternatives and competitors to AbboMax, Inc include Creative Diagnostics, CrossLife Technologies Inc., Bio Synthesis , bioWORLD, Vireo Health, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AbboMax, Inc and Creative Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AbboMax, Inc, https://bouncewatch.com/company/abbomax-inc, updated 28 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes